Chair, James R. Gavin III, MD, PhD, Jens Juul Holst, Professor, MD, Dr.Med.Sci., and Davida F. Kruger, MSN, APN-BC,BC-ADM, discuss GLP-1 RAs for the treatment of T2DM in this CME activity titled “The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/QAM865. CME credit will be available until July 26, 2022.

свернуть